Overview

Garland Taylor Smith is an attorney based in Holland & Knight's Chattanooga office and a member of the Corporate Services and Venture Capital Teams. Mr. Smith advises clients in mergers, acquisitions, private equity and venture capital financings.

Mr. Smith advises investors in venture capital and private equity transactions, mergers and acquisitions (M&A) and provides business advice to clients making direct minority investments (venture and private equity) and acquisition financing.

Representative Experience

  • Represented a private equity-backed clinical stage biopharmaceutical company focused on ocular drug development in its sale to a publicly traded ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for rare ophthalmic diseases
  • Represented EmVenio Research Inc., the largest provider of community-based clinical trial sites served with mobile research units, in its sale to PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials
  • Represented a client as buyer in the acquisition of a majority of the equity of Florida One Insurance Agency LLC, a Delaware limited liability company; the transaction involved a sophisticated pre-closing reorganization
  • Represented a client as buyer in the acquisition of all of the equity of The Benefits Group of Haudenschield, Harrison and Blachek LLC, an insurance brokerage company
  • Represented a client as buyer in the acquisition of all of the equity of IPA 18 LLC, an insurance brokerage company
  • Represented a leading dispute resolution business in its sale to a nationally recognized strategic buyer
  • Represented an insurance technology company in its strategic acquisition of a Colorado-based technology company via a merger
  • Represented a sponsor in the sale of a nationally recognized cafeteria services business
  • Represented a sponsor in the sale of certain distressed assets

  • Represented an investor in the $20 million Series B investment in a media platform software company
  • Represented an investor in the $15 million Series A investment in a healthcare technology company
  • Represented an investor in the $25 million Series C investment in a data technology company
  • Represented an investor in the $25 million Series B investment in a data automation company
  • Represented an information technology company in its $37 million Series B round
  • Represented an investor in the $22 million Series B investment in a healthcare software company
  • Represented an investor in its $14 million secondary purchase
  • Represented a financial wellness technology company in its $6 million Series Seed round
  • Represented an investor in its $10 million Series Seed investment in an information technology company
  • Represented a leading fashion brand in its $27 million Series F financing
  • Represented a leading venture capital (VC) fund in more than 40 SAFE financings
  • Represented a leading VC fund in a $7.5 million convertible note financing
  • Represented a family office in its investment in a luxury private airline business
  • Represented a food services business in its $4 million raise and strategic joint venture (JV) with a manufacturer

  • Represented a client in its entry into a $25 million senior credit facility
  • Represented a client in its entry into a $285 million senior credit facility
  • Represented a client in its entry into an $820 million senior credit facility
  • Represented multiple clients in their entry into acquisition financing arrangements
  • Represented a portfolio company in a more than $800 million senior credit facility
  • Represented multiple portfolio companies in obtaining working capital facilities

Credentials

Education
  • University of Tennessee College of Law, J.D., cum laude
  • Tusculum University, B.A., Business Administration
Bar Admissions/Licenses
  • Connecticut
  • Tennessee
Honors & Awards
  • The Best Lawyers in America guide, Ones to Watch, Chattanooga Corporate Law, Mergers and Acquisitions Law, 2026

Publications

News